These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 230854)

  • 21. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ; Spann R; Nguyenduc M; Lamon EW
    J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.
    Tucker DF; Knight RA; Warne PH
    Clin Exp Metastasis; 1983; 1(3):275-87. PubMed ID: 6100804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancing effect on tumour growth of humoral antibodies against tumour specific transplantation antigens in tumours induced by murine sarcoma virus(Harvey).
    Bubenik J; Turano A
    Nature; 1968 Nov; 220(5170):928-30. PubMed ID: 5722149
    [No Abstract]   [Full Text] [Related]  

  • 28. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
    Mayer AM; Basombrio MA; Pasqualini CD
    Br J Cancer; 1980 Jun; 41(6):966-75. PubMed ID: 6252923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumours induced by Moloney murine sarcoma virus are clonal in rats, not clonal in mice.
    D'Andrea E; Tessarollo L; Menin C; Chieco-Bianchi L
    J Cancer Res Clin Oncol; 1992; 118(2):141-6. PubMed ID: 1735735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E; Mussgay M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma.
    Kimura H; Aoki T
    Br J Cancer; 1978 Apr; 37(4):553-65. PubMed ID: 206273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part I. Biology of tumour regression and recurrence.
    Tucker DF; Knight RA; Warne PH
    Clin Exp Metastasis; 1983; 1(3):261-73. PubMed ID: 6100803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma.
    Giuliani F; Bellini O; Casazza AM; Formelli F; Savi G; Di Marco A
    Eur J Cancer (1965); 1978 May; 14(5):555-66. PubMed ID: 206445
    [No Abstract]   [Full Text] [Related]  

  • 35. Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus.
    Frankel AE; Fischinger PJ
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3705-9. PubMed ID: 185623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro production of immunosuppressive factors by murine sarcoma virus-transformed mouse fibroblasts.
    Mizel SB; DeLarco JE; Todaro GJ; Farrar WL; Hilfiker ML
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2205-8. PubMed ID: 6246526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM; Knight RA
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody activity against evolutionary conserved juxtanuclearly arranged antigen in mice with tumors induced by a progressor Moloney sarcoma virus transformant.
    Weiland E; Weiland F; Thiel HJ
    Exp Cell Biol; 1984; 52(5):300-10. PubMed ID: 6090238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors.
    Gordon J; Holden HT; Segal S; Feldman M
    Int J Cancer; 1982 Mar; 29(3):351-7. PubMed ID: 6978293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.